HEARTBURN RESEARCH TRIAL
We are seeking volunteers at least 18 years old with a history of heartburn episodes for the past 6 months or longer.

PURPOSE OF THE STUDY:  To compare the efficacy and safety of an investigational medication compared either to placebo or to an active comparator (Prevacid™) in relief of GERD (gastroesophageal reflux disease) or EE (erosive esophagitis) symptoms.

STUDY INFORMATION:

• Duration of study participation is 4 to 8 weeks, plus a 7 to 21 day screening period.
• The study medication is an investigational proton pump inhibitor.
• Treatment regimen for GERD study subjects is study medication or placebo; for EE study subjects, the treatment regimen will be study medication or active comparator (Prevacid™).
• There is no charge for participation (study procedures, study medication, etc. are no-cost).
• Compensation will be provided to participants for study-related time and/or travel.
• Principal Investigator: John Goff, M.D. of Rocky Mountain Gastroenterology Associates, P.C.

Contact Western States Clinical Research, Inc.